GABA Receptors and Alcohol Use Disorders: Preclinical Studies

Overview

Journal Curr Top Behav Neurosci

Publisher Springer

Specialty Psychology

Date 2020 Aug 19

PMID 32808090

Citations 6

Authors

August F Holtyn

Elise M Weerts

Affiliations

Soon will be listed here.

Abstract

Preclinical research over the past several decades has demonstrated a role for the γ-aminobutyric acid (GABA) receptor in alcohol use disorder (AUD). This chapter offers an examination of preclinical evidence on the role of the GABA receptor on alcohol-related behaviors with a particular focus on the GABA receptor agonist baclofen, for which effects have been most extensively studied, and positive allosteric modulators (PAMs) of the GABA receptor. Studies employing rodent and non-human primate models have shown that activation of the GABA receptor can reduce (1) stimulating and rewarding effects of alcohol; (2) signs of alcohol withdrawal in rats made physically dependent on alcohol; (3) acquisition and maintenance of alcohol drinking under a two-bottle alcohol versus water choice procedure; (4) alcohol intake under oral operant self-administration procedures; (5) motivational properties of alcohol measured using extinction and progressive ratio procedures; (6) the increase in alcohol intake after a period of alcohol abstinence (the alcohol deprivation effect or ADE); and (7) the ability of alcohol cues and stress to reinstate alcohol seeking when alcohol is no longer available. Baclofen and GABA PAMs reduce the abovementioned behaviors across different preclinical models, which provides strong evidence for a significant role of the GABA receptor in alcohol-related behaviors and supports development of medications targeting GABA receptors for the treatment of AUD. This chapter highlights the value of examining mechanisms of alcohol-related behaviors across multiple animal models to increase the confidence in identification of new therapeutic targets.

Citing Articles

GABAergic compounds for the treatment of alcohol use disorder.

Berro L, Rowlett J, Platt D Int Rev Neurobiol. 2024; 178:383-399.

PMID: 39523061 PMC: 11611293. DOI: 10.1016/bs.irn.2024.08.001.

Chronic ethanol exposure in mice evokes pre- and postsynaptic deficits in GABAergic transmission in ventral tegmental area GABA neurons.

Mitten E, Souders A, Marron Fernandez de Velasco E, Aguado C, Lujan R, Wickman K Br J Pharmacol. 2024; 182(1):69-86.

PMID: 39358985 PMC: 11831720. DOI: 10.1111/bph.17335.

Protein kinase C epsilon-mediated modulation of T-type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus.

Shan H, Smith T, Klorig D, Godwin D Alcohol Clin Exp Res (Hoboken). 2024; 48(7):1278-1288.

PMID: 38740544 PMC: 11807373. DOI: 10.1111/acer.15342.

GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential.

Dharavath R, Pina-Leblanc C, Tang V, Sloan M, Nikolova Y, Pangarov P Front Neural Circuits. 2023; 17:1218737.

PMID: 37929054 PMC: 10623140. DOI: 10.3389/fncir.2023.1218737.

Activation of GABA receptors in central amygdala attenuates activity of PKCδ + neurons and suppresses punishment-resistant alcohol self-administration in rats.

Domi E, Xu L, Toivainen S, Wiskerke J, Coppola A, Holm L Neuropsychopharmacology. 2023; 48(9):1386-1395.

PMID: 36739350 PMC: 10354045. DOI: 10.1038/s41386-023-01543-1.

References

Anstrom K, Cromwell H, Markowski T, Woodward D . Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol Clin Exp Res. 2003; 27(6):900-8. DOI: 10.1097/01.ALC.0000071744.78580.78. View

Arias C, Mlewski E, Molina J, Spear N . Naloxone and baclofen attenuate ethanol's locomotor-activating effects in preweanling Sprague-Dawley rats. Behav Neurosci. 2009; 123(1):172-80. DOI: 10.1037/a0014049. View

Augier E, Dulman R, Damadzic R, Pilling A, Hamilton J, Heilig M . The GABA Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats. Neuropsychopharmacology. 2017; 42(9):1789-1799. PMC: 5520784. DOI: 10.1038/npp.2017.53. View

Baker E, Farro J, Gonzales S, Helms C, Grant K . Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability. Alcohol Clin Exp Res. 2014; 38(11):2835-43. PMC: 4244650. DOI: 10.1111/acer.12547. View

Baker E, Walter N, Salo A, Rivas Perea P, Moore S, Gonzales S . Identifying Future Drinkers: Behavioral Analysis of Monkeys Initiating Drinking to Intoxication is Predictive of Future Drinking Classification. Alcohol Clin Exp Res. 2017; 41(3):626-636. PMC: 5347908. DOI: 10.1111/acer.13327. View

Bechtholt A, Cunningham C . Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav Neurosci. 2005; 119(1):213-23. DOI: 10.1037/0735-7044.119.1.213. View

Becker H . Animal models of alcohol withdrawal. Alcohol Res Health. 2001; 24(2):105-13. PMC: 6713015. View

Besheer J, Lepoutre V, Hodge C . GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology (Berl). 2004; 174(3):358-66. DOI: 10.1007/s00213-003-1769-3. View

Boehm 2nd S, Piercy M, Bergstrom H, Phillips T . Ventral tegmental area region governs GABA(B) receptor modulation of ethanol-stimulated activity in mice. Neuroscience. 2002; 115(1):185-200. DOI: 10.1016/s0306-4522(02)00378-0. View

10.

Broadbent J, Harless W . Differential effects of GABA(A) and GABA(B) agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice. Psychopharmacology (Berl). 1999; 141(2):197-205. DOI: 10.1007/s002130050825. View

11.

Chester J, Cunningham C . Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol Biochem Behav. 1999; 63(2):325-31. DOI: 10.1016/s0091-3057(98)00253-6. View

12.

Cicero T, Snider S, Perez V, Swanson L . Physical dependence on and tolerance to alcohol in the rat. Physiol Behav. 1971; 6(2):191-8. DOI: 10.1016/0031-9384(71)90088-6. View

13.

Colombo G, Agabio R, Carai M, Lobina C, Pani M, Reali R . Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence. Alcohol Clin Exp Res. 2000; 24(1):58-66. View

14.

Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G . The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol. 2002; 37(5):499-503. DOI: 10.1093/alcalc/37.5.499. View

15.

Colombo G, Serra S, Brunetti G, Vacca G, Carai M, Gessa G . Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 2003; 70(1):105-8. DOI: 10.1016/s0376-8716(02)00333-2. View

16.

Colombo G, Vacca G, Serra S, Brunetti G, Carai M, Gessa G . Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl). 2003; 167(3):221-4. DOI: 10.1007/s00213-003-1397-y. View

17.

Colombo G, Serra S, Vacca G, Gessa G, Carai M . Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats. Eur J Pharmacol. 2004; 492(2-3):189-93. DOI: 10.1016/j.ejphar.2004.03.065. View

18.

Colombo G, Serra S, Vacca G, Carai M, Gessa G . Effect of the combination of naltrexone and baclofen, on acquisition of alcohol drinking behavior in alcohol-preferring rats. Drug Alcohol Depend. 2004; 77(1):87-91. DOI: 10.1016/j.drugalcdep.2004.07.003. View

19.

Colombo G, Serra S, Vacca G, Carai M, Gessa G . Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. Eur J Pharmacol. 2006; 550(1-3):123-6. DOI: 10.1016/j.ejphar.2006.08.052. View

20.

Colombo G, Lobina C, Maccioni P, Carai M, Lorrai I, Zaru A . Anxiety-like behaviors at the end of the nocturnal period in sP rats with a "history" of unpredictable, limited access to alcohol. Alcohol. 2015; 49(7):707-12. PMC: 4636466. DOI: 10.1016/j.alcohol.2015.04.010. View